Yahoo Web Search

Search results

    • Pfizer: An Oversold Pharma Stock in Recovery

      Pfizer: An Oversold Pharma Stock in Recovery

      GuruFocus.com via Yahoo Finance· 3 days ago

      Indeed, from a forecast standpoint, the near future looks bright. While revenue will witness only mild growth in the next four years, Ebitda is estimated...

    • Novavax (NASDAQ:NVAX) Shares Gap Down to $19.56

      ETF DAILY NEWS· 6 days ago

      Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $19.56, but opened at $18.79. Novavax shares last ...